Medical cannabis products were exported from Israel for the first time this week, one year after the government approved overseas sales, Revadim-based BOL Pharma said on Tuesday.
BOL Pharma, a IMC-GMP-certified cultivator and supplier of medical cannabis, said it exported its first batch of medical cannabis to a customer in the United Kingdom. The products are destined for centers that specialize in the treatment of children with epilepsy and autism.
“This is truly welcome news and a real breakthrough for the Israeli medical cannabis market,” BOL Pharma CEO Dr. Tamir Gedo said. “The Israeli cannabis industry has a huge competitive edge in the global arena, compared to many countries trying to enter the cannabis sector... Further opening of the market to exports will enable Israel to become a world leader in the coming years.”
Read more at jpost.com
